188 related articles for article (PubMed ID: 32980036)
21. Comparisons of Self-reported Glaucoma Medication Adherence With a New Wireless Device: A Pilot Study.
Gatwood JD; Johnson J; Jerkins B
J Glaucoma; 2017 Nov; 26(11):1056-1061. PubMed ID: 29099436
[TBL] [Abstract][Full Text] [Related]
22. The Most Common Barriers to Glaucoma Medication Adherence: A Cross-Sectional Survey.
Newman-Casey PA; Robin AL; Blachley T; Farris K; Heisler M; Resnicow K; Lee PP
Ophthalmology; 2015 Jul; 122(7):1308-16. PubMed ID: 25912144
[TBL] [Abstract][Full Text] [Related]
23. A comprehensive perspective on patient adherence to topical glaucoma therapy.
Tsai JC
Ophthalmology; 2009 Nov; 116(11 Suppl):S30-6. PubMed ID: 19837258
[TBL] [Abstract][Full Text] [Related]
24. Ocular Antihypertensive Medication Use After iStent Implantation Concurrent With Cataract Surgery vs Cataract Surgery Alone in a Large US Health Care Claims Database.
Wang SY; Singh K; Stein JD; Chang RT
JAMA Ophthalmol; 2019 Jan; 137(1):21-27. PubMed ID: 30267072
[TBL] [Abstract][Full Text] [Related]
25. Intentional and unintentional nonadherence to ocular hypotensive treatment in patients with glaucoma.
Rees G; Leong O; Crowston JG; Lamoureux EL
Ophthalmology; 2010 May; 117(5):903-8. PubMed ID: 20153902
[TBL] [Abstract][Full Text] [Related]
26. Impact of a health communication intervention to improve glaucoma treatment adherence. Results of the interactive study to increase glaucoma adherence to treatment trial.
Glanz K; Beck AD; Bundy L; Primo S; Lynn MJ; Cleveland J; Wold JA; Echt KV
Arch Ophthalmol; 2012 Oct; 130(10):1252-8. PubMed ID: 22688429
[TBL] [Abstract][Full Text] [Related]
27. The Relationship of Self-Report and Medication Possession With Glaucoma Medication Administration Success.
Hein AM; Rosdahl JA; Bosworth HB; Woolson SL; Olsen MK; Kirshner MA; Muir KW
J Glaucoma; 2019 Mar; 28(3):e46-e48. PubMed ID: 30822299
[TBL] [Abstract][Full Text] [Related]
28. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring.
Hermann MM; Bron AM; Creuzot-Garcher CP; Diestelhorst M
J Glaucoma; 2011 Oct; 20(8):502-8. PubMed ID: 20852438
[TBL] [Abstract][Full Text] [Related]
29. Glaucoma Patient Preferences for Video Education on Eye Drop Technique.
Davis SA; Carpenter DM; Blalock SJ; Budenz DL; Lee C; Muir KW; Robin AL; Sleath B
Optom Vis Sci; 2019 May; 96(5):325-330. PubMed ID: 31046014
[TBL] [Abstract][Full Text] [Related]
30. Development and validation of a predictive model for nonadherence with once-daily glaucoma medications.
Chang DS; Friedman DS; Frazier T; Plyler R; Boland MV
Ophthalmology; 2013 Jul; 120(7):1396-402. PubMed ID: 23541760
[TBL] [Abstract][Full Text] [Related]
31. Psychometric Properties of the Reduced Version of the Glaucoma Treatment Compliance Assessment Tool (GTCAT).
Barker GT; Mansberger SL
Ophthalmic Epidemiol; 2019 Feb; 26(1):55-62. PubMed ID: 30204034
[TBL] [Abstract][Full Text] [Related]
32. Readability of prescription labels and medication recall in a population of tertiary referral glaucoma patients.
O'Hare F; Jeganathan VS; Rokahr CG; Rogers SL; Crowston JG
Clin Exp Ophthalmol; 2009 Dec; 37(9):849-54. PubMed ID: 20092593
[TBL] [Abstract][Full Text] [Related]
33. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity.
Sleath B; Blalock S; Covert D; Stone JL; Skinner AC; Muir K; Robin AL
Ophthalmology; 2011 Dec; 118(12):2398-402. PubMed ID: 21856009
[TBL] [Abstract][Full Text] [Related]
34. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia.
Mehari T; Giorgis AT; Shibeshi W
BMC Ophthalmol; 2016 Aug; 16():131. PubMed ID: 27485739
[TBL] [Abstract][Full Text] [Related]
35. A study of the association between patterns of eye drop prescription and medication usage in glaucoma subjects.
Kawai-Tsuboi N; Kawai M; Minami Y; Yoshida A
J Glaucoma; 2015 Mar; 24(3):202-6. PubMed ID: 23807351
[TBL] [Abstract][Full Text] [Related]
36. Persistence of patients receiving topical glaucoma monotherapy in an Asian population.
Quek DT; Ong GT; Perera SA; Lamoureux EL; Aung T
Arch Ophthalmol; 2011 May; 129(5):643-8. PubMed ID: 21220621
[TBL] [Abstract][Full Text] [Related]
37. The relationship between sociodemographic factors and persistence with topical glaucoma medications.
Leung VC; Jin YP; Hatch W; Mammo Z; Trope GE; Buys YM; Macrae WG
J Glaucoma; 2015 Jan; 24(1):69-76. PubMed ID: 25055210
[TBL] [Abstract][Full Text] [Related]
38. Impact of the introduction of generic latanoprost on glaucoma medication adherence.
Stein JD; Shekhawat N; Talwar N; Balkrishnan R
Ophthalmology; 2015 Apr; 122(4):738-47. PubMed ID: 25680226
[TBL] [Abstract][Full Text] [Related]
39. Glaucoma severity and medication adherence in a county hospital population.
Ung C; Zhang E; Alfaro T; Murakami Y; Zhang M; Seider MI; Lin SC; Singh K
Ophthalmology; 2013 Jun; 120(6):1150-7. PubMed ID: 23453512
[TBL] [Abstract][Full Text] [Related]
40. Treatment patterns and medication adherence of patients with glaucoma in South Korea.
Kim CY; Park KH; Ahn J; Ahn MD; Cha SC; Kim HS; Kim JM; Kim MJ; Kim TW; Kim YY; Lee JW; Park SW; Sohn YH; Sung KR; Yoo C; Cha J; Kim YJ
Br J Ophthalmol; 2017 Jun; 101(6):801-807. PubMed ID: 28270490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
